tm logo

Monitor this mark

View On USPTO

SPYRE THERAPEUTICS
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 03 Oct 2024

Last Applicant/ Owned by

SPYRE THERAPEUTICS, INC.

BUILDING 23, SUITE 105

WALTHAM

MA

02453

Serial Number

98251421 filed on 02th Nov 2023

Registration Number

N/A

Correspondent Address

Bethany A. Stokes

Bethany A. Stokes GREENBERG TRAURIG, LLP

SUITE 2000

BOSTON, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SPYRE THERAPEUTICS

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders and immune system related diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98251421

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 22073030300

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

03.23.15 -

Micro-organisms (including sperms)

Legal History

Show more

Status DateAction Taken
03rd Oct 2024SUSPENSION LETTER WRITTEN
03rd Oct 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03rd Oct 2024LETTER OF SUSPENSION E-MAILED
19th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
19th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
19th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
03rd Sep 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03rd Sep 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
13th Jun 2024ASSIGNED TO EXAMINER
13th Jun 2024NON-FINAL ACTION WRITTEN